MedPath

Bioresorbable Intramedullary Nailing of Forearm Fractures

Not Applicable
Recruiting
Conditions
Forearm Fracture
Interventions
Other: MRI Scan
Registration Number
NCT04846543
Lead Sponsor
Thomas Klestil
Brief Summary

The Activa IM-Nail™ is used in the fixation of forearm fractures with cast to achieve a level of reduction and stabilisation that is appropriate to the age of the child. The post-market clinical follow-up study will be performed to identify the residual risk related to re-fracture and to determine its impact to the risk/benefit ratio of Activa IM-Nail™.

Detailed Description

Residual risk related to re-fracture rate will be addressed by this PMCF study. The research question is, if the re-fracture risk with Activa IM-nail is in line with the other treatment methods, namely ESIN.

Primary objective: will be to assess clinical outcome by determining re-fracture rate of all treated patients, difference of re-fracture rate depending on the fracture type determined by X-ray (e.g. greenstick vs. non-greenstick fracture), subject's age, BMI, surgical technique, immobilization time and bony union formation.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Diaphyseal forearm fractures (radius or ulna or both)
  • Patients from 3 years to under 13 years, but the age limits depend on the biological development of the child and in addition
Exclusion Criteria
  • multifragmentary fractures, metaphyseal and epiphyseal fractures
  • Situations where internal fixation is otherwise contraindicated, e.g., active or potential infection, or where a patient's cooperation cannot be guaranteed.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MRI scan 1st and 2nd yearMRI ScanAdditionally to routinely follow up, there will be an MRI scan of enrolled patients after one and two years in some of the study sites
Primary Outcome Measures
NameTimeMethod
Refracture rateFirst year after operation

Assessment of refracture rate

Secondary Outcome Measures
NameTimeMethod
Absorption of implantOne and two years after operation

MRI scans are performed to evaluate soft tissue reaction and biodegradability

Bony unionOne year after operation

Bony union depending on fracture type and immobilization time, return to sport

Monteggia lesion and equivalent2 years after operation

Safety and performance of operative technique in Monteggia´s lesion

Cost effectiveness1 year after operation

HTA assessment for different health care systems in Europe

Trial Locations

Locations (9)

Landesklinikum Moedling

🇦🇹

Mödling, Lower Austria, Austria

Pécs University Hospital, Department of Pediatrics

🇭🇺

Pécs, Hungary

Péterfy Hospital, National Trauma Center, Department of Pediatric Trauma Surgery

🇭🇺

Budapest, Hungary

Hospital Pediátrico - CHUC, EPE

🇵🇹

Coimbra, Portugal

Lille University Center, Jeanne de Flandre Hospital

🇫🇷

Lille, France

Centre Hospitalier Universitaire Vaudois

🇨🇭

Lausanne, Switzerland

University Medical Center Schleswig-Holstein, Campus Lübeck Department of Pediatric Surgery

🇩🇪

Lübeck, Schleswig-Holstein, Germany

Herlev and Gentofte University Hospital Department of Orthopedic Surgery

🇩🇰

Herlev, Denmark

Hvidovre Hospital

🇩🇰

Hvidovre, Denmark

© Copyright 2025. All Rights Reserved by MedPath